Funding Briefs

More research money may be going to AIDS, but other immune deficiences are still underfunded and under-researched, says Marcia Boyle, president of the Immune Deficiency Disease Foundation. To encourage work on the primary immune deficiencies, the foundation is starting a faculty development award of $20,000 for each of three years to go to a young researcher in the first three years of a faculty appointment. The award will be funded by pharmaceutical supplier Cutter Biological, a subsidiary of

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

More research money may be going to AIDS, but other immune deficiences are still underfunded and under-researched, says Marcia Boyle, president of the Immune Deficiency Disease Foundation. To encourage work on the primary immune deficiencies, the foundation is starting a faculty development award of $20,000 for each of three years to go to a young researcher in the first three years of a faculty appointment. The award will be funded by pharmaceutical supplier Cutter Biological, a subsidiary of Miles Inc., West Haven, Conn. Applications for the 1989 award will be due January 13,1989. The foundation also coordinates a training grant for postdocs funded by Sandoz Pharmaceutical. The 1989 award will provide $15,000 a year for two years, and Boyle says that the 1990 award will go up to $30,000 a year for each of the two years.

For application forms, write to the Immune Deficiency Foundation, P.O. Box 586, Columbia, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies